Current through the 2023 Legislative Session.
Section 125291.40 - California Stem Cell Research and Cures Finance Committee(a) Solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this article, the California Stem Cell Research and Cures Finance Committee is hereby created. For purposes of this article, the California Stem Cell Research and Cures Finance Committee is "the committee" as that term is used in the State General Obligation Bond Law. The committee consists of the Treasurer, the Controller, the Director of Finance, the Chairperson of the California Institute for Regenerative Medicine, and two other members of the Independent Citizens Oversight Committee (as created by the act) chosen by the Chairperson of the California Institute for Regenerative Medicine, or their designated representatives. The Treasurer shall serve as chairperson of the committee. A majority of the committee may act for the committee. (b) For purposes of the State General Obligation Bond Law, the California Institute for Regenerative Medicine is designated the "board." Ca. Health and Saf. Code § 125291.40
Amended by Proposition 71, Sec. 5, enacted by the people of the State of California 11/2/2004, eff. 11/3/2004.